Insights from 2023 ESMO Annual Meeting
Playback speed
10 seconds
ESMO 2023 Insights: "The DEEPER Trial - m-FOLFOXIRI + Cetuximab Treatment & Predictive Clinical Factors for RAS/BRAF Wild-Type and Left-Sided mCRC"
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Yu Sunakawa
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Yu Sunakawa
66 views
October 31, 2023
Comments 0
Login to view comments.
Click here to Login
Gastrointestinal